JUNCTIONAL EPIDERMOLYSIS BULLOSA
Clinical trials for JUNCTIONAL EPIDERMOLYSIS BULLOSA explained in plain language.
Never miss a new study
Get alerted when new JUNCTIONAL EPIDERMOLYSIS BULLOSA trials appear
Sign up with your email to follow new studies for JUNCTIONAL EPIDERMOLYSIS BULLOSA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New gel tested to heal fragile skin in 'Butterfly Children' disease
Disease control Recruiting nowThis study is testing a gel called TCP-25 to see if it can help heal skin wounds in people with Epidermolysis Bullosa (EB), a rare condition that causes extremely fragile skin. Researchers will compare the gel to a placebo (vehicle) gel by applying each to a different matching wo…
Matched conditions: JUNCTIONAL EPIDERMOLYSIS BULLOSA
Phase: PHASE2 • Sponsor: Xinnate AB • Aim: Disease control
Last updated Mar 27, 2026 12:40 UTC
-
New gel offers hope for healing fragile skin in rare genetic condition
Disease control Recruiting nowThis study is testing whether Oleogel-S10 gel helps close wounds in people with two types of epidermolysis bullosa (EB), a rare genetic condition that causes fragile, blistering skin. Japanese children and adults with confirmed EB will apply the gel to their wounds for 45 days wh…
Matched conditions: JUNCTIONAL EPIDERMOLYSIS BULLOSA
Phase: PHASE3 • Sponsor: Chiesi Farmaceutici S.p.A. • Aim: Disease control
Last updated Mar 25, 2026 14:07 UTC